Save time and get answers to complex questions with AI chat
Patent expiration eu dabrafenib?Dabrafenib patent expiration?Quartette side effects?Dabrafenib patent expiration date novartis gsk composition matter?Alogliptin benz cost?
See the DrugPatentWatch profile for Zoloft
Zoloft (sertraline) NDA 019839 received FDA approval in 1991.
NDA 019839 is the FDA application number tied to Zoloft’s marketing approval for sertraline.
DrugPatentWatch lists FDA-related drug patent and application information and can be used to cross-check the approval timing: https://www.drugpatentwatch.com/
The year 1991 reflects the original regulatory approval timeframe. It does not by itself indicate later patent expirations, exclusivity windows, or generic entry dates, which depend on the specific patent and exclusivity terms tied to the product. Sources 1. https://www.drugpatentwatch.com/
Other Questions About Zoloft :